Cargando…

Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients

Increasing evidences support that systemic inflammation-based prognostic scores, modified Glasgow Prognostic Score (mGPS), C-reactive Protein/Albumin (CRP/ALB), Albumin/Globulin (AGR), Prognostic Nutritional Index (PNI) and Advanced Lung cancer Inflammation index (ALI), are key determinants of patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ting, Zhao, Yuanyang, Zhao, Shen, Yang, Yunpeng, Huang, Yan, Hou, Xue, Zhao, Hongyun, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547997/ https://www.ncbi.nlm.nih.gov/pubmed/31205524 http://dx.doi.org/10.7150/jca.29319

Ejemplares similares

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients
por: Liu, Tingting, et al.
Publicado: (2021)

Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study
por: Li, Yuanyuan, et al.
Publicado: (2017)

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
por: Zheng, Qiufan, et al.
Publicado: (2020)

Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
por: Zhou, Ting, et al.
Publicado: (2015)

Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis
por: Zhou, Ting, et al.
Publicado: (2020)

SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012)

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
por: Zhao, Hongyun, et al.
Publicado: (2013)

Myeloid cell leukemia-1 is an important predictor of survival and progression of small cell lung cancer
por: Zhou, Ting, et al.
Publicado: (2020)

Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)
por: Zhou, Ting, et al.
Publicado: (2017)

Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis
por: Wang, Feng, et al.
Publicado: (2022)

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients
por: Fang, Chao, et al.
Publicado: (2022)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection
por: Wu, Yunhua, et al.
Publicado: (2019)

Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
por: Liang, Wenhua, et al.
Publicado: (2014)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy
por: Zhang, Lilong, et al.
Publicado: (2023)

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis
por: Zhang, Zhonghan, et al.
Publicado: (2019)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
por: Zhou, Yixin, et al.
Publicado: (2018)

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study
por: Zhao, Shen, et al.
Publicado: (2020)

The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
por: Jiang, Chunyang, et al.
Publicado: (2022)

Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma
por: Ye, Sisi, et al.
Publicado: (2018)

A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients
por: Chao, Bei, et al.
Publicado: (2020)

Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2021)

Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection
por: Ma, Bingqi, et al.
Publicado: (2021)

Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
por: Zhang, Yaxiong, et al.
Publicado: (2019)

Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma
por: Zheng, Chen, et al.
Publicado: (2020)

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma
por: Zuo, Ran, et al.
Publicado: (2023)

Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study
por: Liu, Jiaqing, et al.
Publicado: (2019)

Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
por: Chen, Bo, et al.
Publicado: (2019)

The Prognostic Value of Multiple Systemic Inflammatory Biomarkers in Preoperative Patients With Non-small Cell Lung Cancer
por: Wang, Kai, et al.
Publicado: (2022)

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
por: Pan, Mingmei, et al.
Publicado: (2021)

The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments
por: Luo, Yuanfu, et al.
Publicado: (2021)

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
por: Leitch, E F, et al.
Publicado: (2007)

Advanced Lung Cancer Inflammation Index is a Prognostic Factor of Patients with Small-Cell Lung Cancer Following Surgical Resection
por: Hu, Zhonghui, et al.
Publicado: (2021)

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis
por: Zhang, Yaxiong, et al.
Publicado: (2016)

Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
por: Qiu, Zhi-Xin, et al.
Publicado: (2015)

Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer
por: Chen, Dongfang, et al.
Publicado: (2022)

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer
por: Zhang, Zhonghan, et al.
Publicado: (2020)

Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen
por: Zhao, Jun, et al.
Publicado: (2012)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jbve6fspq5o5fk43pk3la6lamg